BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30733559)

  • 1. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
    Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
    Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
    Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
    Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satellite cells deficiency and defective regeneration in dynamin 2-related centronuclear myopathy.
    F Almeida C; Bitoun M; Vainzof M
    FASEB J; 2021 Apr; 35(4):e21346. PubMed ID: 33715228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
    Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
    Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
    Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
    Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
    Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
    J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired excitation-contraction coupling in muscle fibres from the dynamin2
    Kutchukian C; Szentesi P; Allard B; Trochet D; Beuvin M; Berthier C; Tourneur Y; Guicheney P; Csernoch L; Bitoun M; Jacquemond V
    J Physiol; 2017 Dec; 595(24):7369-7382. PubMed ID: 29071728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells.
    González-Jamett AM; Baez-Matus X; Olivares MJ; Hinostroza F; Guerra-Fernández MJ; Vasquez-Navarrete J; Bui MT; Guicheney P; Romero NB; Bevilacqua JA; Bitoun M; Caviedes P; Cárdenas AM
    Sci Rep; 2017 Jul; 7(1):4580. PubMed ID: 28676641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
    Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
    Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
    Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
    Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
    Tinelli E; Pereira JA; Suter U
    Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing dynamin 2 (DNM2) rescues
    Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
    Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
    J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin.
    Massana Muñoz X; Kretz C; Silva-Rojas R; Ochala J; Menuet A; Romero NB; Cowling BS; Laporte J
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32809972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dynamin-2-gene related centronuclear myopathy].
    Bitoun M
    Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():6-10. PubMed ID: 37975763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.
    Liewluck T; Lovell TL; Bite AV; Engel AG
    Neuromuscul Disord; 2010 Dec; 20(12):801-4. PubMed ID: 20817456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
    Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
    Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A centronuclear myopathy-causing mutation in dynamin-2 disrupts neuronal morphology and excitatory synaptic transmission in a murine model of the disease.
    Arriagada-Diaz J; Flores-Muñoz C; Gómez-Soto B; Labraña-Allende M; Mattar-Araos M; Prado-Vega L; Hinostroza F; Gajardo I; Guerra-Fernández MJ; Bevilacqua JA; Cárdenas AM; Bitoun M; Ardiles AO; Gonzalez-Jamett AM
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12918. PubMed ID: 37317811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.
    Tasfaout H; Lionello VM; Kretz C; Koebel P; Messaddeq N; Bitz D; Laporte J; Cowling BS
    Mol Ther; 2018 Apr; 26(4):1082-1092. PubMed ID: 29506908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dog model for centronuclear myopathy carrying the most common DNM2 mutation.
    Böhm J; Barthélémy I; Landwerlin C; Blanchard-Gutton N; Relaix F; Blot S; Laporte J; Tiret L
    Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35244154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.